Senate Judiciary To Mark Up Drug Patent, FDA-PTO Collaboration Bills

The Senate Judiciary Committee will meet Thursday (Feb. 9) to take up five bipartisan bills aimed at lowering prescription drug costs by addressing common drug patent abuses and fostering better collaboration between FDA and the U.S. Patent and Trademark Office (USPTO). Each bill was introduced during the 117th Congress and passed through the committee at different times over the last two years. A Democratic aide to the committee recently told Politico the bills have a good shot at passing...